Back to the article

HealthRX.com · Printable medication review sheet

Constipation on Zepbound that has not settled: treatment review record

Fill this in before the review the page describes: your bowel pattern before Zepbound, every product tried with its ingredient, amount and how long you used it, what is still difficult, and the questions a clinician is likely to ask. Product limits from the labels and the warning signs that should not wait are printed on the same page.

Companion to “Zepbound (Tirzepatide) Constipation That Won't Go Away: Causes, Management, and When to Worry” · healthrx.com/side-effects-zepbound-constipation/when-it-doesnt-resolve · Facts checked 2026-10-18

Before and since Zepbound

Bowel pattern before Zepboundhow often, and what stools were like
When constipation started, and your dose at the time
Current dose and date of the last change
Meals, drinks and fiber sources now
Medicines added recentlyname, dose and timing

Every product you have tried

Copy the ingredient and amount from the label. Write what changed, not only whether it worked.

ProductActive ingredientAmount per doseDoses a dayDates usedWhat changed: frequency, stool form, straining

What is still difficult

  • Fewer bowel movements than my usual
  • Hard or lumpy stools
  • Straining
  • Feeling that I have not fully emptied
  • Bloating or abdominal pain
  • Blood on the toilet paper or in the stool

Label and guideline limits to check against

  • MiraLAX Drug Facts: 17 g once a day dissolved in 4 to 8 ounces of a drink, for no more than 7 days of self-use; it generally produces a bowel movement in 1 to 3 days.[1]
  • MiraLAX Drug Facts: stop and ask a doctor if you need a laxative for longer than 1 week.[1]
  • AGA-ACG guideline: avoid magnesium oxide with kidney insufficiency because of the risk of high magnesium.[2]
  • Linzess label for adult chronic idiopathic constipation: 145 mcg once daily, or 72 mcg based on presentation or tolerability; dosing is suspended if severe diarrhea occurs.[3]
  • NIDDK: blood tests can show signs of anemia, hypothyroidism and celiac disease; endoscopies for constipation include colonoscopy and flexible sigmoidoscopy.[4]

Get evaluated instead of adding another product

  • Severe pain in the stomach area that will not go away, with or without nausea or vomiting: stop Zepbound and call your healthcare provider right away.[5]
  • Ileus, intestinal obstruction and severe constipation with fecal impaction are in the Zepbound label's postmarketing reports.[5]
  • Rectal bleeding, or nausea, bloating, cramping or abdominal pain that gets worse while using MiraLAX: stop and ask a doctor.[1]

Questions the review may cover

  1. How often do I have a bowel movement now, and how long has this lasted?
  2. What do my stools look like, and has there been any blood?
  3. Have I had digestive surgery, recent weight change or anemia?
  4. Which tests, if any, fit my symptoms and examination?
  5. Which prescription option, if any, matches my diagnosis, and what does its label say?
Sources for the facts on this sheet
  1. Cardinal Health 107, LLC, via DailyMed. MiraLAX (polyethylene glycol 3350) powder for oral solution: Drug Facts. Effective 2025-11-07. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1771d3bf-954d-49ea-b260-3d356e5dcfa5
  2. Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. Am J Gastroenterol 2023. PMID 37204227. https://pubmed.ncbi.nlm.nih.gov/37204227/
  3. Allergan, Inc., via DailyMed. Linzess (linaclotide) capsules, for oral use: prescribing information. Effective 2026-05-21. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3
  4. National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of Constipation. Accessed 2026-10-18. https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/diagnosis
  5. Eli Lilly and Company, via DailyMed. Zepbound (tirzepatide) injection, for subcutaneous use: prescribing information and Medication Guide. Effective 2026-08-28. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b

This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.